RPSAP7

Across TCGA pan-cancer cohorts, RPSAP7 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of RPSAP7’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where RPSAP7 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPSAP7 is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.

LIHC, COAD, and STAD are the cancer types where RPSAP7 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPSAP7 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	Female	All	+0.401	<.001	8	view →
COAD	Female	III,IV	−1.012	.015	4	view →
STAD	All	IV	+0.173	.015	4	view →
CHOL	All	All	+0.402	.001	3	view →
PRAD	All	All	+0.205	.015	2	view →
UCEC	All	IV	+0.165	.042	2	view →
KICH	Male	II,III,IV	+0.636	.022	1	view →
LUAD	Female	All	+0.518	.009	1	view →
LUSC	Male	All	+0.353	.013	1	view →
KIRP	All	All	+0.287	.030	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

RPSAP7–LIHC

Open the LIHC breakdown →